![]()
|
|||
| |
|||
Misleading Kaposi's Sarcoma: Usefulness of
Anti HHV-8 Immunostining
Audard V, Lok C, Trabattoni M, Wechsler J, Brousse
N, Fraitag S.
Ann Pathol.
23(4): 345-8, 2003 ____________________________________________________________________________ Ocular Surface Impression Cytology McKelvie P Impression cytology, either using cellulose acetate strips or the Biopore membrane device, is a simple,
noninvasive technique that aids in the diagnosis of several disorders of the
ocular surface. These disorders include ocular surface squamous
neoplasia, dry eye syndrome, limbal
stem-cell deficiency, specific viral infections, vitamin A deficiency, allergic
disorders, conjunctival melanosis,
and malignant melanoma. Another advantage is the preservation of limbal stem cells, which occur in the basal layer of the limbal epithelium and are responsible for renewal of the
corneal epithelium. The Biopore membrane device is
particularly user friendly, with little expertise required and adequate
specimens obtained in a very high percentage of cases. The most common
applications in diagnostic ocular pathology are:(i) primary diagnosis and follow-up of ocular surface squamous neoplasia, including
after therapy with topical mitomycin C. The
sensitivity is high (78-87%); and (ii) dry eye syndrome where squamous metaplasia and/ or
hyperkeratosis are noted. Certain limitations of the technique for diagnosis of
squamous neoplasia include
the fact that dysplasias are often keratinizing and
may yield very few or even no dysplastic cells with
impression cytology. Secondly, no definite cytologic
criteria reliably distinguish invasive SCC of ocular surface from in situ
disease. Other applications include the rapid specific diagnosis of ocular
surface infections with herpes simplex, adeno-, and varicella zoster viruses. Impression cytology samples may
also be used to obtain mRNA, cells for phenotyping by
flow cytometry, and proteins for Western blotting for
research studies. Adv Anat
Pathol 10(6): 328-37, ________________________________________________________________________
Apolipoprotein B May Be Sniderman AD et al
Apolipoprotein B (apoB) appears to represent a
better index of risk than does low-density lipoprotein cholesterol (LDLC)
level. The study showed that
patients who had a high triglyceride level and a high apoB
were the ones more likely to have high blood sugar, more insulin resistance,
more inflammation, and more prothrombogenic factors.
The investigators analyzed data from 1522 subjects, ages 49 to 69 years old.
"Hyper-LDLC" was defined as levels of 130 mg/dL
or higher, and "hyper-apoB" 99 mg/dL or higher. Approximately 10% of subjects met the
definition for elevated LDLC but not for apoB, and
another 10% had elevated apoB in the presence of
normal LDLC. After combining these two groups, the authors note, 19% of the
cohort would have a different treatment recommendation if apoB
were used to guide treatment instead of LDLC. According to their findings, normo-LDLC hyper-apoB individuals
have significantly lower mean age, HDL cholesterol, and LDL particle size and
higher body mass index, waist circumference, triglycerides, fasting insulin,
2-hour insulin, and plasminogen activator inhibit-1
values than the hyper-LDLC normo-apoB group. The data relate back to
fatty acid metabolism. If patients have excess energy intake, it is difficult
for adipose tissue to store fatty acids, which in turn increases cardiovascular
risk. Authors suggest two choices for assessing patients at risk. In his own practice, Sniderman measures apoB as part of a routine panel. An alternative is that when patients present with high triglyceride levels or a low HDL, measuring apoB would produce a more complete estimate of patient risk and potential for benefit from statin treatment. Circulation, Volume 108,No.19, ________________________________________________________________________ Dengue Fever Mimicking Plasma Cell
Leukemia
Gawoski JM and
Winnie W. Ooi Extreme plasmacytosis in peripheral blood is a rare finding most
often associated with plasma cell leukemia but rarely with other malignancies,
infectious diseases, or drug reactions.
Authors report the case of a 40-year-old man who was a Arch Pathol Lab Med 127,
10261027, 2003 ________________________________________________________________________ American Diabetes
Association An international expert committee aligned to re-examine the diagnostic
and classification criteria for diabetes announced new guidelines for doctors
to use when looking for pre-diabetes. The recommendations are published
in the November 2003 issue of Diabetes Care. The acceptable results
of one method used to identify pre-diabetes, impaired fasting glucose, have
been changed from <110 mg/dl to <100 mg/dl. Using the new criteria,
the number of Americans classified as having pre-diabetes is expected to rise
by twenty percent. Diabetic Care 26: 3160-3167,
2003 ____________________________________________________________________________ |
|||
| Back Home | |||